{"mainPropery":{"diseaseId":9415,"diseaseName":"Paraneoplastic Neurologic Disorders","hasGardWebPage":true,"isRare":true,"websiteUrl":"https://rarediseases.info.nih.gov/diseases/9415/paraneoplastic-neurologic-disorders","synonyms":["PND"],"synonyms-with-source":[{"name":"PND"}],"identifiers":[]},"diseaseCategories":[{"diseaseTypeId":28,"diseaseTypeName":"Hereditary Cancer Syndromes"}],"organizations":[{"resourceID":120,"resourceName":"American Cancer Society","abbreviation":"","address1":"250 Williams Street NW","address2":"","address3":"","address4":"","address5":"","city":"Atlanta","state":"GA","zip":"30329","country":"United States","phone":"","tty":"","tollFree":"1-800-227-2345","fax":"","email":"","url":"https://www.cancer.org","freeText":""},{"resourceID":933,"resourceName":"American Autoimmune Related Diseases Association","abbreviation":"AARDA","address1":"19176 Hall Road, Suite 130","address2":"","address3":"","address4":"","address5":"","city":"Clinton Township","state":"MI","zip":"48038","country":"United States","phone":"586-776-3900","tty":"","tollFree":"800-598-4668","fax":"586-776-3903","email":"aarda@aarda.org","url":"https://www.aarda.org/","freeText":""},{"resourceID":3767,"resourceName":"International Autoimmune Encephalitis Society","abbreviation":"","address1":"","address2":"","address3":"","address4":"","address5":"","city":"","state":"","zip":"","country":"United States","phone":"352-527-2470","tty":"","tollFree":"","fax":"","email":"IAES@autoimmune-encephalitis.org","url":"https://autoimmune-encephalitis.org/","freeText":""}],"resource descriptions":[{"id":336,"resourceId":1154,"resourceName":"RareConnect","descriptionText":"<div style=\"margin-top: 0px; margin-bottom: 0px;\"><a href='https://www.rareconnect.org/en/community/paraneoplastic-neurological-syn' target='_blank'>RareConnect</a> has an online community for patients&nbsp;and families with this condition so they can connect with others and share&nbsp;their experiences living with a rare disease.&nbsp;The project is a joint collaboration between EURORDIS (European Rare Disease Organisation) and NORD (National Organization for Rare Disorders).</div>","resourceClassificationName":"Organizations","resourceClassificationSectionName":"Social Networking Websites"},{"id":1527,"resourceId":2159,"resourceName":"National Organization for Rare Disorders","descriptionText":"The <a href='http://www.rarediseases.org/rare-disease-information/rare-diseases/byID/1187/viewAbstract' target='_blank'>National Organization for Rare Disorders</a> (NORD) has a report for patients and families about this condition. NORD is a patient advocacy organization for individuals with rare diseases and the organizations that serve them.<br />\r\n","resourceClassificationName":"Overview","resourceClassificationSectionName":"Where to Start"},{"id":1530,"resourceId":2161,"resourceName":"National Institute of Neurological Disorders and Stroke (NINDS)","descriptionText":"The <a href='http://www.ninds.nih.gov/disorders/paraneoplastic/paraneoplastic.htm' target='_blank'>National Institute of Neurological Disorders and Stroke</a> (NINDS) collects and disseminates research information related to neurological disorders. Click on the link to view information on&nbsp;this topic.","resourceClassificationName":"Overview","resourceClassificationSectionName":"Where to Start"},{"id":1531,"resourceId":2162,"resourceName":"Medscape Reference","descriptionText":"<a href='http://www.emedicine.com/med/TOPIC1747.HTM' target='_blank'>Medscape Reference</a> provides information on this topic. You may need to register to view the medical textbook, but registration is free.<br />\r\n","resourceClassificationName":"Overview","resourceClassificationSectionName":"In-Depth Information"},{"id":1553,"resourceId":2171,"resourceName":"National Cancer Institute","descriptionText":"The <a href='http://cis.nci.nih.gov' target='_blank'>National Cancer Institute</a> (CIS)  provides the most current information on cancer for patients, health professionals, and the general public. You can reach them by calling toll-free at 1-800-422-6237 or by visiting their Web site. ","resourceClassificationName":"Overview","resourceClassificationSectionName":"Where to Start"},{"id":2557,"resourceId":3873,"resourceName":"IAES Diagnosis and Treatment","descriptionText":"The <a href=\"https://autoimmune-encephalitis.org/diagnosis/\" target=\"_blank\">International Autoimmune Encephalitis Society</a> offers patients and families detailed information on diagnosis and treatment.","resourceClassificationName":"Overview","resourceClassificationSectionName":"Where to Start"},{"id":2558,"resourceId":3875,"resourceName":"IAES Facebook","descriptionText":"<span style=\"font-size: 11.5pt; font-family: Segoe\\ UI, sans-serif; color: #212121;\">The <a target=\"_blank\" href=\"https://www.facebook.com/groups/251477975360/\">International Autoimmune Encephalitis Society Facebook group</a> offers educational support through this forum.</span>","resourceClassificationName":"Organizations","resourceClassificationSectionName":"Social Networking Websites"},{"id":2559,"resourceId":3877,"resourceName":"Paraneoplastic disorder Free Full-text","descriptionText":"McKeonA. <a target=\"_blank\" href=\"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3726118/\">Paraneoplastic and other autoimmune disorders of the central nervous system</a>. Neurohospitalist. 2013 Apr; 3(2):53-64.","resourceClassificationName":"Overview","resourceClassificationSectionName":"Selected Full-Text Journal Articles"},{"id":2560,"resourceId":3877,"resourceName":"Paraneoplastic disorder Free Full-text","descriptionText":"Jammoul A, Li Y, Rae-Grant A. <a target=\"_blank\" href=\"https://www.mdedge.com/sites/default/files/issues/articles/Jammoul_Autoantibody-mediatedEncephalitis.pdf\">Autoantibody-Â­mediated encephalitis: Not just paraneoplastic, not just limbic, and not untreatable</a>. Cleveland Clinic Journal of Medicine. 2016 January;83(1):43-53.","resourceClassificationName":"Overview","resourceClassificationSectionName":"Selected Full-Text Journal Articles"},{"id":2583,"resourceId":3768,"resourceName":"Autoimmune Encephalitis - articles","descriptionText":"Binks SNM, Klein CJ, Waters P, Pittock SJ, Irani SR. <a href=\"http://jnnp.bmj.com/content/early/2017/10/21/jnnp-2017-315720\" target=\"_blank\">LGI1, CASPR2 and related antibodies: a molecular evolution of the phenotypes</a>.  J Neurol Neurosurg Psychiatry. 2018 May;89(5):526-534.","resourceClassificationName":"Overview","resourceClassificationSectionName":"Selected Full-Text Journal Articles"}],"overviewQuestion":{"questionId":1322,"questionText":"What are paraneoplastic neurologic disorders?","answerText":"<strong>Paraneoplastic neurologic disorders</strong> are a group of rare degenerative conditions that are triggered by a person's immune system response to a cancerous tumor.&nbsp;Researchers believe these&nbsp;disorders occur when cancer-fighting <a href=\"http://www.nlm.nih.gov/medlineplus/ency/article/002223.htm\" target=\"_blank\">antibodies</a> or white blood cells known as <a href=\"http://www.nationalmssociety.org/What-is-MS/Definition-of-MS/T-cells\" target=\"_blank\">T cells</a> mistakenly attack normal cells in the nervous system. Paraneoplastic neurologic disorders typically develop after mid-adulthood and are most common in people with lung, ovarian, lymphatic, or breast cancer. Symptoms generally develop over a period of days to weeks and usually occur prior to tumor detection. These symptoms may include difficulty in walking and/or swallowing, loss of muscle tone, loss of fine motor coordination, slurred speech, memory loss, vision problems, sleep disturbances, <a href=\"http://www.ninds.nih.gov/disorders/dementias/dementia.htm\" target=\"_blank\">dementia</a>, <a href=\"http://www.ninds.nih.gov/disorders/epilepsy/epilepsy.htm\" target=\"_blank\">seizures</a>, sensory loss in the limbs, and <a href=\"http://www.nlm.nih.gov/medlineplus/dizzinessandvertigo.html\" target=\"_blank\">vertigo</a>. Paraneoplastic neurologic disorders include <a href=\"https://rarediseases.info.nih.gov/gard/6851/lambert-eaton-myasthenic-syndrome/resources/1\" target=\"_blank\">Lambert-Eaton myasthenic syndrome</a>, <a href=\"https://rarediseases.info.nih.gov/gard/5023/stiff-person-syndrome/resources/1\" target=\"_blank\">stiff-person syndrome</a>, encephalomyelitis (inflammation of the brain and spinal cord), <a href=\"https://rarediseases.info.nih.gov/gard/7122/myasthenia-gravis/resources/1\" target=\"_blank\">myasthenia gravis</a>, <a href=\"https://rarediseases.info.nih.gov/diseases/7326/paraneoplastic-cerebellar-degeneration\" target=\"_blank\">cerebellar degeneration</a>, <a href=\"http://www.ninds.nih.gov/disorders/encephalitis_meningitis/encephalitis_meningitis.htm\" target=\"_blank\">limbic and/or brainstem encephalitis</a>, <a href=\"http://www.ninds.nih.gov/disorders/isaacs_syndrome/isaacs_syndrome.htm\" target=\"_blank\">neuromyotonia</a>, and <a href=\"http://www.ninds.nih.gov/disorders/opsoclonus_myoclonus/opsoclonus_myoclonus.htm\" target=\"_blank\">opsoclonus</a> (involving eye movement) and <a href=\"http://www.ninds.nih.gov/disorders/peripheralneuropathy/detail_peripheralneuropathy.htm\" target=\"_blank\">sensory neuropathy</a>.[791][11681] Treatment involves treatment of the underlying tumor, <a href=\"http://www.cancer.org/treatment/treatmentsandsideeffects/treatmenttypes/immunotherapy/immunotherapy-what-is-immunotherapy\" target=\"_blank\">immunotherapy</a>, and supportive therapy.[11682]","dateModified":"2016-06-09T00:00:00"},"basicQuestions":[{"questionId":1324,"questionText":"What is the prognosis for people with a paraneoplastic neurologic disorder?","answerText":"The prognosis for people with a paraneoplastic neurologic disorder depends on the type of paraneoplastic disorder and the type of cancer with which they are diagnosed.[791]&nbsp;There are no cures for paraneoplastic disorders and resulting progressive neurological damage. Prompt treatment of the underlying tumor and <a href=\"http://www.cancer.org/treatment/treatmentsandsideeffects/treatmenttypes/immunotherapy/immunotherapy-what-is-immunotherapy\" target=\"_blank\">immunotherapy</a> may be beneficial in stabilizing a person's neurologic symptoms.[792][11681] Less often, treatment of the tumor improves the neurologic symptoms.[11681]","dateModified":"2016-06-09T00:00:00","resourceClassificationName":"Prognosis","references":[{"referenceId":791,"authors":"","articleTitle":"NINDS Paraneoplastic Syndromes Information Page","bookWebsiteJournalTitle":"National Institute of Neurological Disorders and Stroke Website","date":"March 12, 2009","volume":"","pages":"","url":"https://www.ninds.nih.gov/Disorders/All-Disorders/Paraneoplastic-Syndromes-Information-Page","dateAccessed":"2016-06-09T00:00:00","authors2":"","placeOfPublication":"","publisher":""},{"referenceId":792,"authors":"Dalmau J, Rosenfeld M","articleTitle":"Paraneoplastic neurologic syndromes","bookWebsiteJournalTitle":"Abeloff's Clinical Oncology, 4th ed","date":"2008","pages":"767-778","authors2":"Abeloff MD, Armitage JO, Niederhuber JE, Kastan MB, McKenna WG","placeOfPublication":"Philadelphia","publisher":"Churchill Livingstone"},{"referenceId":11681,"authors":"Josep Dalmau, Myrna R Rosenfeld","articleTitle":"Overview of paraneoplastic syndromes of the nervous system","bookWebsiteJournalTitle":"UpToDate","date":"October 5, 2015","volume":"","pages":"","url":"http://www.uptodate.com/contents/overview-of-paraneoplastic-syndromes-of-the-nervous-system","authors2":"","placeOfPublication":"","publisher":""}]}],"references":[],"relatedDiseases":[{"relatedDiseaseId":12041,"relatedDiseaseName":"Melanoma-associated retinopathy","relation":"Parent","isRare":true,"hasGardPage":true}],"gardCases":[{"caseId":22737,"abbreviatedInquiry":"If the symptoms of paraneoplastic neurologic disorders are caused by cancer, why do the symptoms appear before cancer is diagnosed? What is the prognosis?","caseQuestions":[{"questionId":1322,"questionText":"What are paraneoplastic neurologic disorders?","answerText":"<strong>Paraneoplastic neurologic disorders</strong> are a group of rare degenerative conditions that are triggered by a person's immune system response to a cancerous tumor.&nbsp;Researchers believe these&nbsp;disorders occur when cancer-fighting <a href=\"http://www.nlm.nih.gov/medlineplus/ency/article/002223.htm\" target=\"_blank\">antibodies</a> or white blood cells known as <a href=\"http://www.nationalmssociety.org/What-is-MS/Definition-of-MS/T-cells\" target=\"_blank\">T cells</a> mistakenly attack normal cells in the nervous system. Paraneoplastic neurologic disorders typically develop after mid-adulthood and are most common in people with lung, ovarian, lymphatic, or breast cancer. Symptoms generally develop over a period of days to weeks and usually occur prior to tumor detection. These symptoms may include difficulty in walking and/or swallowing, loss of muscle tone, loss of fine motor coordination, slurred speech, memory loss, vision problems, sleep disturbances, <a href=\"http://www.ninds.nih.gov/disorders/dementias/dementia.htm\" target=\"_blank\">dementia</a>, <a href=\"http://www.ninds.nih.gov/disorders/epilepsy/epilepsy.htm\" target=\"_blank\">seizures</a>, sensory loss in the limbs, and <a href=\"http://www.nlm.nih.gov/medlineplus/dizzinessandvertigo.html\" target=\"_blank\">vertigo</a>. Paraneoplastic neurologic disorders include <a href=\"https://rarediseases.info.nih.gov/gard/6851/lambert-eaton-myasthenic-syndrome/resources/1\" target=\"_blank\">Lambert-Eaton myasthenic syndrome</a>, <a href=\"https://rarediseases.info.nih.gov/gard/5023/stiff-person-syndrome/resources/1\" target=\"_blank\">stiff-person syndrome</a>, encephalomyelitis (inflammation of the brain and spinal cord), <a href=\"https://rarediseases.info.nih.gov/gard/7122/myasthenia-gravis/resources/1\" target=\"_blank\">myasthenia gravis</a>, <a href=\"https://rarediseases.info.nih.gov/diseases/7326/paraneoplastic-cerebellar-degeneration\" target=\"_blank\">cerebellar degeneration</a>, <a href=\"http://www.ninds.nih.gov/disorders/encephalitis_meningitis/encephalitis_meningitis.htm\" target=\"_blank\">limbic and/or brainstem encephalitis</a>, <a href=\"http://www.ninds.nih.gov/disorders/isaacs_syndrome/isaacs_syndrome.htm\" target=\"_blank\">neuromyotonia</a>, and <a href=\"http://www.ninds.nih.gov/disorders/opsoclonus_myoclonus/opsoclonus_myoclonus.htm\" target=\"_blank\">opsoclonus</a> (involving eye movement) and <a href=\"http://www.ninds.nih.gov/disorders/peripheralneuropathy/detail_peripheralneuropathy.htm\" target=\"_blank\">sensory neuropathy</a>.[791][11681] Treatment involves treatment of the underlying tumor, <a href=\"http://www.cancer.org/treatment/treatmentsandsideeffects/treatmenttypes/immunotherapy/immunotherapy-what-is-immunotherapy\" target=\"_blank\">immunotherapy</a>, and supportive therapy.[11682]","dateModified":"2016-06-09T00:00:00","references":[{"referenceId":791,"authors":"","articleTitle":"NINDS Paraneoplastic Syndromes Information Page","bookWebsiteJournalTitle":"National Institute of Neurological Disorders and Stroke Website","date":"March 12, 2009","volume":"","pages":"","url":"https://www.ninds.nih.gov/Disorders/All-Disorders/Paraneoplastic-Syndromes-Information-Page","dateAccessed":"2016-06-09T00:00:00","authors2":"","placeOfPublication":"","publisher":""},{"referenceId":11681,"authors":"Josep Dalmau, Myrna R Rosenfeld","articleTitle":"Overview of paraneoplastic syndromes of the nervous system","bookWebsiteJournalTitle":"UpToDate","date":"October 5, 2015","volume":"","pages":"","url":"http://www.uptodate.com/contents/overview-of-paraneoplastic-syndromes-of-the-nervous-system","authors2":"","placeOfPublication":"","publisher":""},{"referenceId":11682,"authors":"Sudheeran Kannoth","articleTitle":"Paraneoplastic neurologic syndrome: A practical approach","bookWebsiteJournalTitle":"Annals of Indian Academy of Neurology","date":"Jan-Mar 2012","volume":"15(1)","pages":"6-12","url":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3299076/","authors2":"","placeOfPublication":"","publisher":""}]},{"questionId":1323,"questionText":"Why do the symptoms of a paraneoplastic neurologic disorder&nbsp;appear before cancer is diagnosed?","answerText":"The symptoms of a paraneoplastic neurologic disorder&nbsp;are caused by the presence of a cancerous tumor.[791]&nbsp;At first, the tumor is&nbsp;too small to be detected. The body starts to respond by producing cancer-fighting <a href=\"http://www.nlm.nih.gov/medlineplus/ency/article/002223.htm\" target=\"_blank\">antibodies</a> or white blood cells known as <a href=\"http://ghr.nlm.nih.gov/glossary=tlymphocyte\" target=\"_blank\">T cells</a>. Researchers believe paraneoplastic neurologic disorder occur when&nbsp;the body mistakenly attacks normal cells in the nervous system. Two-thirds of patients  develop neurologic symptoms before any cancer is detected.[792]","dateModified":"2016-12-30T00:00:00","references":[{"referenceId":791,"authors":"","articleTitle":"NINDS Paraneoplastic Syndromes Information Page","bookWebsiteJournalTitle":"National Institute of Neurological Disorders and Stroke Website","date":"March 12, 2009","volume":"","pages":"","url":"https://www.ninds.nih.gov/Disorders/All-Disorders/Paraneoplastic-Syndromes-Information-Page","dateAccessed":"2016-06-09T00:00:00","authors2":"","placeOfPublication":"","publisher":""},{"referenceId":792,"authors":"Dalmau J, Rosenfeld M","articleTitle":"Paraneoplastic neurologic syndromes","bookWebsiteJournalTitle":"Abeloff's Clinical Oncology, 4th ed","date":"2008","pages":"767-778","authors2":"Abeloff MD, Armitage JO, Niederhuber JE, Kastan MB, McKenna WG","placeOfPublication":"Philadelphia","publisher":"Churchill Livingstone"}]},{"questionId":1324,"questionText":"What is the prognosis for people with a paraneoplastic neurologic disorder?","answerText":"The prognosis for people with a paraneoplastic neurologic disorder depends on the type of paraneoplastic disorder and the type of cancer with which they are diagnosed.[791]&nbsp;There are no cures for paraneoplastic disorders and resulting progressive neurological damage. Prompt treatment of the underlying tumor and <a href=\"http://www.cancer.org/treatment/treatmentsandsideeffects/treatmenttypes/immunotherapy/immunotherapy-what-is-immunotherapy\" target=\"_blank\">immunotherapy</a> may be beneficial in stabilizing a person's neurologic symptoms.[792][11681] Less often, treatment of the tumor improves the neurologic symptoms.[11681]","dateModified":"2016-06-09T00:00:00","resourceClassificationName":"Prognosis","references":[{"referenceId":791,"authors":"","articleTitle":"NINDS Paraneoplastic Syndromes Information Page","bookWebsiteJournalTitle":"National Institute of Neurological Disorders and Stroke Website","date":"March 12, 2009","volume":"","pages":"","url":"https://www.ninds.nih.gov/Disorders/All-Disorders/Paraneoplastic-Syndromes-Information-Page","dateAccessed":"2016-06-09T00:00:00","authors2":"","placeOfPublication":"","publisher":""},{"referenceId":792,"authors":"Dalmau J, Rosenfeld M","articleTitle":"Paraneoplastic neurologic syndromes","bookWebsiteJournalTitle":"Abeloff's Clinical Oncology, 4th ed","date":"2008","pages":"767-778","authors2":"Abeloff MD, Armitage JO, Niederhuber JE, Kastan MB, McKenna WG","placeOfPublication":"Philadelphia","publisher":"Churchill Livingstone"},{"referenceId":11681,"authors":"Josep Dalmau, Myrna R Rosenfeld","articleTitle":"Overview of paraneoplastic syndromes of the nervous system","bookWebsiteJournalTitle":"UpToDate","date":"October 5, 2015","volume":"","pages":"","url":"http://www.uptodate.com/contents/overview-of-paraneoplastic-syndromes-of-the-nervous-system","authors2":"","placeOfPublication":"","publisher":""}]}]}],"news":[{"newsId":671,"dateCreated":"2020-05-20T13:39:00","publishDate":"2020-05-22T00:00:00","title":"NIH-Supported Research Survey to Examine Impact of COVID-19 on Rare Diseases Community","description":"The NIH-funded Rare Diseases Clinical Research Network (RDCRN) has launched an <a href=\"https://www.rarediseasesnetwork.org/COVIDsurvey \" target=\"_blank\">online research survey</a> to find out how the COVID-19 pandemic is impacting individuals with rare diseases, their families and their caregivers. Your participation can help the rare disease research community shed light on the needs of people with rare diseases during this and other potential health crises, in addition to informing future research efforts. The survey must be completed by December 15, 2020.","url":"https://www.rarediseasesnetwork.org/COVIDsurvey","lastModified":"2020-11-30T14:44:00","isFeatured":false}],"conferences":[],"phenoTypes":[],"medicalProducts":[],"EncodedName":"Paraneoplastic_Neurologic_Disorders"}